{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "18300015", "DateCompleted": {"Year": "2008", "Month": "05", "Day": "15"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"Language": ["eng"], "ELocationID": ["10.1080/00207450701593160"], "ArticleDate": [], "Journal": {"ISSN": "0020-7454", "JournalIssue": {"Volume": "118", "Issue": "3", "PubDate": {"Year": "2008", "Month": "Mar"}}, "Title": "The International journal of neuroscience", "ISOAbbreviation": "Int J Neurosci"}, "ArticleTitle": "Effect of growth hormone on Cyclooxygenase-2 expression in the hippocampus of rats chronically exposed to ozone.", "Pagination": {"StartPage": "455", "EndPage": "469", "MedlinePgn": "455-69"}, "Abstract": {"AbstractText": ["The aim of this study was to determine GH-effects on Cyclooxygenase-2 (COX-2) expression on hippocampus alterations caused by ozone exposure. Seventy male rats were divided into: (1) control; (2) exposed to ozone for 7, 15, and 30 days; (3) exposed to ozone and treated with GH, for 7, 15, and 30 days. Results showed that lipoperoxidation levels and number of COX-2-positive cells increased in all groups exposed to ozone compared to control. In the groups treated with GH, COX-2 immunoreactive cell number decreased with respect to the ozone group. Therefore, GH could provide protection against damage induced by oxidative stress."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Physiology Department, School of Medicine, National Autonomous University of Mexico, Mexico-City, Mexico DF."}], "Identifier": [], "LastName": "Mart\u00ednez-Canabal", "ForeName": "Alonso", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Angoa-P\u00e9rez", "ForeName": "Mariana", "Initials": "M"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rugerio-Vargas", "ForeName": "Concepci\u00f3n", "Initials": "C"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Borgonio-Perez", "ForeName": "Gabino", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Rivas-Arancibia", "ForeName": "Selva", "Initials": "S"}], "PublicationTypeList": ["Evaluation Study", "Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Int J Neurosci", "NlmUniqueID": "0270707", "ISSNLinking": "0020-7454"}, "ChemicalList": [{"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "9002-72-6", "NameOfSubstance": "Growth Hormone"}, {"RegistryNumber": "EC 1.14.99.1", "NameOfSubstance": "Cyclooxygenase 2"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects", "genetics", "metabolism"], "DescriptorName": "Cyclooxygenase 2"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Growth Hormone"}, {"QualifierName": ["metabolism"], "DescriptorName": "Hippocampus"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "2", "Day": "27", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "5", "Day": "16", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "2", "Day": "27", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18300015", "10.1080/00207450701593160", "790907879"]}}], "PubmedBookArticle": []}